Jump to content
RemedySpot.com

16% of drug-naive entering GSK US studies already have resistance

Rate this topic


Guest guest

Recommended Posts

16% of drug-naive entering GSK US studies already have resistance

Sixteen per cent of treatment-naïve patients enrolling in Glaxo Kline-sponsored clinical trials in the United States in 2005 already had resistance to at least one antiretroviral drug, according to data presented by company researchers at the Forty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco on Thursday.

Read More >>

Regards, Vergelpowerusa dot org"Act with a determination not to be turned aside by thoughts of the past and fears of the future."- E. Lee

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...